Prudential Financial’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,861
Closed -$269K 2806
2024
Q3
$269K Sell
3,861
-155
-4% -$10.6K ﹤0.01% 2430
2024
Q2
$270K Buy
4,016
+173
+5% +$11.7K ﹤0.01% 2394
2024
Q1
$265K Sell
3,843
-32,312
-89% -$2.18M ﹤0.01% 2377
2023
Q4
$2.25M Buy
36,155
+110
+0.3% +$6.15K ﹤0.01% 1367
2023
Q3
$2.05M Sell
36,045
-672
-2% -$37.8K ﹤0.01% 1349
2023
Q2
$1.85M Sell
36,717
-2,019
-5% -$107K ﹤0.01% 1453
2023
Q1
$2.11M Sell
38,736
-8,728
-18% -$510K ﹤0.01% 1308
2022
Q4
$2.97M Sell
47,464
-9,322
-16% -$619K 0.01% 1117
2022
Q3
$4M Buy
56,786
+8,366
+17% +$577K 0.01% 954
2022
Q2
$2.74M Sell
48,420
-31,965
-40% -$1.75M ﹤0.01% 1219
2022
Q1
$5.03M Buy
80,385
+36,163
+82% +$1.95M 0.01% 982
2021
Q4
$2.63M Buy
44,222
+14,760
+50% +$902K ﹤0.01% 1382
2021
Q3
$1.95M Buy
29,462
+652
+2% +$44.5K ﹤0.01% 1477
2021
Q2
$1.83M Buy
+28,810
New +$1.7M ﹤0.01% 1524

Other funds holding AXNX

Prudential Financial's AXNX Position: Q4 2024 in Review

Prudential Financial sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 3,861 shares — an estimated $269K sold.

Prudential Financial first reported a position in AXNX in Q2 2021 and held it in 14 quarters. The position peaked at $5.03M in Q1 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Prudential Financial reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Prudential Financial sold 3,861 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $269K.
  • Prudential Financial first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 14 quarters.
  • Prudential Financial's Axonics, Inc. Common Stock position peaked at $5.03M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Prudential Financial's 13F filing for Q4 2024, filed 11 Feb 2025.